United States
Manufacturer/ Producer
Mooxno was founded in January 2000 by Duke with the purpose of providing quality medical supplies to improve the lives of our customers and to support their personal independence. We care about the quality of our products and we strive to provide the best possible medical supplies at the highest value. Mooxno has been a professional vendor of medical equipment & supplies to hospitals, clinics, healthcare facilities, medical professionals, businesses and government agencies. We now have 75 product series, 1965 Partners hospitals and clinics, 1873 DME products Mission Mooxno makes unique health care, medical products available to our customers at the best possible prices Vision Mooxno strives to be the best Medical Equipment service provider by offering our customers quality products while maintaining our focus on service and values Values Clarity, trust, loyalty, pride and respect - these are our values. They have accompanied us since our beginning and will contuinue to do so in the future. They are the constants which shape our work and our behaviour Partner Benefits Up to 180 days payment term Payment low 10% in advance , balance L/C Confidentiality agreement Full refund agreement Quality assurance agreement International trade legal contract
Manufacturer/ Producer
99 Wall St #4949
NY 10005 New York - United States
Switzerland
Novostia, a Swiss startup founded in 2017, has entrusted MPS with the manufacture of its TRIFLO artificial valve, a revolutionary aortic prosthesis on several levels. Thanks to its aerodynamic design, the presence of three leaflets and the absence of physical pivot axes for the leaflets, the TRIFLO valve aims to satisfy the following three criteria: - A device lifespan at least equal to that of the patient, to avoid the need for a second surgical procedure. This means more than 30 million flap openings and closures per year, with no leaks, blockages, cracks, ruptures or flap escapes. - The artificial valve must not lead to thrombosis, so that patients do not need to take anticoagulants. - Operation (flap opening and closing, blood flow through the valve) must be as silent as possible, so as not to disturb the patient or those around him, day or night. The TRIFLO device is in clinical trial and is not approved for sale.
Request for a quoteCreate one request and get multiple quotes form verified suppliers.